-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CDPzVmvgBQh+v+T7tWGTh1W2cq5MMz238nthx0bRPkdE+jmB0D+DTX5n3/9lOLWg FMwXyLAU9GRnzg4SpUSFBQ== 0001156973-08-000868.txt : 20081015 0001156973-08-000868.hdr.sgml : 20081015 20081015125413 ACCESSION NUMBER: 0001156973-08-000868 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20081015 FILED AS OF DATE: 20081015 DATE AS OF CHANGE: 20081015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASML HOLDING NV CENTRAL INDEX KEY: 0000937966 STANDARD INDUSTRIAL CLASSIFICATION: SPECIAL INDUSTRY MACHINERY, NEC [3559] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33463 FILM NUMBER: 081124476 BUSINESS ADDRESS: STREET 1: DE RUN 6501 CITY: DR VELDHOVEN STATE: P7 ZIP: 5504 BUSINESS PHONE: 31402683000 MAIL ADDRESS: STREET 1: P.O. BOX 324 CITY: AH VELDHOVEN STATE: P7 ZIP: 5500 FORMER COMPANY: FORMER CONFORMED NAME: ASM LITHOGRAPHY HOLDING NV DATE OF NAME CHANGE: 19950215 6-K 1 u56735e6vk.htm FORM 6-K e6vk
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
REPORT OF A FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For October 15, 2008
 
ASML Holding N.V.
De Run 6501
5504 DR Veldhoven
The Netherlands
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F þ     Form 40-F o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o     No þ
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
THIS REPORT ON FORM 6-K IS INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-13332), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-105600), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-109154), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-144356), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-147128), AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-153277) OF ASML HOLDING N.V.
 
 

 


TABLE OF CONTENTS

Exhibits
SIGNATURES
Exhibit 99.1
Exhibit 99.2
Exhibit 99.3


Table of Contents

(ASML LOGO)
Exhibits
99.1   “ASML announces 2008 Third Quarter Results — ASML addresses weak market with lower costs and strong product line-up,” press release dated October 15, 2008
99.2   Summary U.S. GAAP Consolidated Statements of Operations
99.3   Summary IFRS Consolidated Statements of Operations
“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.
SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  ASML HOLDING N.V. (Registrant)
 
 
Date: October 15, 2008  By:   /s/ Peter T.F.M. Wennink    
    Peter T.F.M. Wennink   
    Executive Vice President
and Chief Financial Officer 
 

2

EX-99.1 2 u56735exv99w1.htm EXHIBIT 99.1 exv99w1
Exhibit 99.1
Media Relations Contacts
Lucas van Grinsven — Corporate Communications — +31 40 268 3949 — Veldhoven, the Netherlands
Investor Relations Contacts
Craig DeYoung — Investor Relations — +1 480 383 4005 — Tempe, Arizona, USA
Franki D’Hoore — Investor Relations — +31 40 268 6494 — Veldhoven, the Netherlands
ASML announces 2008 Third Quarter Results
ASML addresses weak market with lower costs and strong product line-up
VELDHOVEN, the Netherlands, October 15, 2008 — ASML Holding NV (ASML) today announces 2008 third quarter results according to US GAAP as follows:
  Q3 2008 net sales of EUR 696 million versus Q2 2008 net sales of EUR 844 million (Q3 2007 net sales of EUR 934 million).
  Q3 2008 net income of EUR 73 million or 10.5 percent of net sales versus Q2 2008 net income of EUR 192 million or 22.7 percent of net sales (Q3 2007 net income of EUR 166 million or 17.8 percent of net sales).
  Q3 2008 net bookings valued at EUR 498 million with 31 systems including 18 new and 13 used systems, leading to an order backlog valued at EUR 1,028 million as of September 28, 2008.
“Sales and profit in the third quarter were in line with our guidance thanks to our leading position in immersion lithography products where market demand has held up despite a weak global economy and credit turmoil,” said Eric Meurice, president and CEO of ASML. “Generating 75 percent of our net sales and 87 percent of our bookings in the quarter, our immersion systems enable customers to aggressively reduce their cost per function in a difficult semiconductor environment. Demand for capacity expansion systems remained weak and as guided we lowered our expenses significantly in response to a softening business environment,” Meurice said.

Page 1 of 5


 

Operations Update
In Q3 2008, ASML’s net sales of EUR 696 million included 26 new and 11 used systems, totaling net system sales of EUR 591 million, and net service and field options sales of EUR 105 million. Net system sales for Q2 2008 included the shipment of 31 new and 8 used machines, totaling EUR 726 million, and net service and field options sales of EUR 118 million.
The Q3 2008 average selling price for a new system was stable at EUR 21.6 million, compared with the Q2 2008 average selling price for a new system of EUR 21.7 million, reflecting the focus on our most advanced technology. The Q3 2008 average selling price for all ASML systems sold was EUR 16.0 million, compared with the Q2 2008 ASP of EUR 18.6 million, as a result of a larger proportion of used systems.
Q3 2008 net bookings totaled 31 systems valued at EUR 498 million. The orders contained 18 new systems with an average selling price for new systems of EUR 22.1 million and 13 used systems with an average selling price of EUR 7.7 million. We received bookings for 16 immersion systems, four of which for used systems.
ASML’s order backlog as of September 28, 2008 was EUR 1,028 million, totaling 53 systems with an average selling price of EUR 19.4 million. For comparison, ASML’s backlog as of June 29, 2008 was valued at EUR 1,106 million, totaling 59 systems with an average selling price of EUR 18.8 million.
In Q3 2008, ASML generated a net income of EUR 73 million or EUR 0.17 per ordinary share as compared with a net income of EUR 192 million in Q2 2008 or EUR 0.45 per ordinary share including non-recurring tax income of approximately EUR 70 million.
The company’s Q3 2008 gross margin was 38.1 percent, compared with the Q2 2008 gross margin of 40.0 percent, consistent with a lower level of net sales.
Q3 2008 research and development (R&D) costs were EUR 130 million net of credits, stable compared with Q2 2008 R&D costs of EUR 130 million net of credits.

Page 2 of 5


 

Selling, general and administrative (SG&A) costs were EUR 52 million in Q3 2008, compared with SG&A costs of EUR 56 million in Q2 2008.
Net cash from operations was EUR 21 million in Q3 2008, impacted by push-outs of planned systems into 2009. ASML ended Q3 2008 with EUR 1,313 million in cash and cash equivalents.
Outlook
“The current economic turmoil and the reassessment by some of our customers of their investments and strategic alliances make it difficult for us to guide on short term bookings or give a mid term sales forecast. However, we received orders for 16 immersion systems in the third quarter, which is a testimonial to the strength of our advanced product portfolio. Even during this downturn, continued immersion technology investments remain necessary for technology transitions and we expect to see quarterly sales at levels that should secure a positive operating profit margin. This will be supported by our ability to further adjust costs with our outsourced business flexibility model. ASML’s strong financial position will allow for sustained strategic investments in technology development and production facilities that will be required for success when the industry recovers. Indeed, we will be shipping in H1 2009 our latest TWINSCAN™ XT:1950i immersion system which offers a 25 percent performance improvement compared to our current leading architecture and takes single exposure imaging down to 38 nanometers. In addition to investing in a new double patterning lithography platform to address the 32 nanometer node and beyond, we are making significant investments in Extreme Ultraviolet (EUV) in order to lead the industry into the next generation technology. We just unveiled a production system roadmap that supports cost-effective chip manufacturing to 22 nanometers and beyond, and have orders for five production systems with delivery starting in 2010,” Meurice said.
In view of the wait-and-see attitude of the market, the company expects to ship 26 systems in Q4 2008 with an average selling price of EUR 20.6 million for new systems and an average selling price for all systems of EUR 16.5 million. As previously guided, ASML’s 2008 full year net sales will decline around 20 percent and the company will

Page 3 of 5


 

thereby outperform peers. ASML expects a gross margin in Q4 2008 of approximately 36 percent, R&D expenditures to be at EUR 124 million net of credits and SG&A costs to decrease to EUR 47 million. We have used and will use the flexibility in our organizational model to reduce costs without forced redundancies.
About ASML
ASML is the world’s leading provider of lithography systems for the semiconductor industry, manufacturing complex machines that are critical to the production of integrated circuits or chips. Headquartered in Veldhoven, the Netherlands, ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. ASML has more than 6,900 employees, serving chip manufacturers in more than 60 locations in 16 countries. For more information, visit our website: www.asml.com
IFRS Financial Reporting
ASML’s primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting standard generally accepted in the United States. Quarterly US GAAP statements of operations, statements of cash flows and balance sheets, and a reconciliation of net income and equity from US GAAP to IFRS are available on www.asml.com
In addition to reporting financial figures in accordance with US GAAP, ASML also reports financial figures in accordance with IFRS for statutory purposes. The most significant differences between US GAAP and IFRS that affect ASML concern the capitalization of certain product development costs, the accounting of stock option plans and the accounting of income taxes. Quarterly IFRS statements of operations, statements of cash flows, balance sheets and a reconciliation of net income and equity from US GAAP to IFRS are available on www.asml.com
The consolidated balance sheets of ASML Holding N.V. as of September 28, 2008, the related consolidated statements of operations and consolidated statements of cash flows for the quarter ended September 28, 2008 as presented in this press release are unaudited.

Page 4 of 5


 

Investor and Media Call
A conference call for investors and media will be hosted by CEO Eric Meurice and CFO Peter Wennink at 15:00 PM Central European Time / 09:00 AM Eastern U.S. time. Dial-in numbers are: in the Netherlands +31 20 531 5856 and the US +1 706 679 0473. To listen to the conference call, access is also available via www.asml.com
A presentation about 2008 third quarter results is available on www.asml.com
A video statement of CFO Peter Wennink is available on www.asml.com
A replay of the Investor and Media Call will be available on www.asml.com
Forward Looking Statements
“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

Page 5 of 5

EX-99.2 3 u56735exv99w2.htm EXHIBIT 99.2 exv99w2
Exhibit 99.2
ASML — Summary U.S. GAAP Consolidated Statements of Operations 1,4
                                 
    Three months ended,     Nine months ended,  
(in thousands EUR, except per share data)   Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
 
                               
Net system sales
    843,232       590,723       2,516,425       2,136,296  
Net service and field option sales
    91,142       105,770       296,842       323,562  
 
Total net sales
    934,374       696,493       2,813,267       2,459,858  
 
                               
Cost of sales
    549,411       431,062       1,653,220       1,483,334  
 
Gross profit on sales
    384,963       265,431       1,160,047       976,524  
 
                               
Research and development costs, net of credits
    120,077       130,157       356,829       388,657  
Amortization of in process R&D
                23,148        
Selling, general and administrative costs
    56,045       51,933       168,771       165,628  
 
Income from operations
    208,841       83,341       611,299       422,239  
 
                               
Interest income
    9,527       7,059       27,958       17,633  
 
Income from operations before income taxes
    218,368       90,400       639,257       439,872  
 
                               
Provision for income taxes
    (52,089 )     (17,106 )     (160,797 )     (29,478 )
 
Net income
    166,279       73,294       478,460       410,394  
 
                               
Basic net income per ordinary share
    0.35       0.17       1.01       0.95  
Diluted net income per ordinary share
    0.35  2,3      0.17  3      1.00  2,3      0.94  3
 
                               
Number of ordinary shares used in computing per share amounts (in thousands):                        
Basic
    474,557       431,672       472,842       431,498  
Diluted
    481,724  2,3     434,491  3     479,881  2,3     434,859  3
ASML — Ratios and Other Data 1,4
                                 
    Three months ended,     Nine months ended,  
    Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
 
                               
Gross profit as a % of net sales
    41.2       38.1       41.2       39.7  
Income from operations as a % of net sales
    22.4       12.0       21.7       17.2  
Net income as a % of net sales
    17.8       10.5       17.0       16.7  
Shareholders’ equity as a % of total assets
    35.7       50.3       35.7       50.3  
Income taxes as a % of income before income taxes
    23.9       18.9       25.2       6.7  
Sales of systems total (in units)
    59       37       205       126  
ASP of systems sales (EUR million)
    14.3       16.0       12.3       17.0  
Value of backlog systems total (EUR million)
    1,769       1,028       1,769       1,028  
Backlog systems total (in units)
    90       53       90       53  
ASP of backlog systems (EUR million)
    19.7       19.4       19.7       19.4  
Value of bookings systems total (EUR million)
    857       498       2,167       1,443  
Net bookings total (in units)
    40       31       132       90  
ASP of bookings systems (EUR million)
    21.4       16.1       16.4       16.0  
Number of employees
    6,403       6,907       6,403       6,907  

 


 

ASML — Summary U.S. GAAP Consolidated Balance Sheets 1,4
                 
(in thousands EUR)   Dec 31, 2007     Sep 28, 2008  
 
 
               
ASSETS
               
 
               
Cash and cash equivalents
    1,271,636       1,312,993  
Accounts receivable, net
    637,975       574,230  
Inventories, net
    1,102,210       1,134,039  
Deferred tax assets short-term
    73,019       82,767  
Other current assets
    234,529       261,341  
 
Total current assets
    3,319,369       3,365,370  
 
               
Deferred tax assets long-term
    141,032       139,351  
Other assets
    59,991       50,632  
Goodwill
    128,271       129,238  
Other intangible assets, net
    38,195       28,846  
Property, plant and equipment, net
    380,894       503,057  
 
Total assets
    4,067,752       4,216,494  
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
 
               
Current liabilities
    1,321,437       1,273,016  
Deferred tax and other liabilities
    245,415       215,182  
Other deferred liabilities
    7,936       8,749  
Other long-term debt
    602,016       596,699  
 
Total liabilities
    2,176,804       2,093,646  
 
               
Shareholders’ equity
    1,890,948       2,122,848  
 
Total liabilities and shareholders’ equity
    4,067,752       4,216,494  

 


 

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows 1,4
                                 
    Three months ended,     Nine months ended,  
(in thousands EUR)   Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
 
                               
CASH FLOWS FROM OPERATING ACTIVITIES
                               
 
                               
Net income
    166,279       73,294       478,460       410,394  
 
                               
Depreciation and amortization
    28,008       29,177       105,527       86,298  
Disposals of property, plant and equipment
    1,698       1,413       12,572       3,828  
Share-based payments
    3,675       3,687       10,342       10,362  
Change in tax assets and liabilities
    (5,306 )     (5,970 )     24,274       (98,283 )
Change in assets and liabilities
    (20,024 )     (80,747 )     (10,083 )     5,584  
 
Net cash provided by operating activities
    174,330       20,854       621,092       418,183  
 
                               
CASH FLOWS FROM INVESTING ACTIVITIES
                               
 
                               
Purchases of property, plant and equipment
    (49,676 )     (68,237 )     (125,188 )     (188,711 )
Proceeds from sale of property, plant and equipment
                3,355        
Purchases of intangible assets
          (35 )           (35 )
Acquisition of subsidiary (net of cash acquired)
                (188,011 )      
 
Net cash used in investing activities
    (49,676 )     (68,272 )     (309,844 )     (188,746 )
 
                               
CASH FLOWS FROM FINANCING ACTIVITIES
                               
 
                               
Purchase of shares in conjunction with conversion rights of bond holders and stock options
                (156,253 )     (87,603 )
Dividend paid
          (394 )           (107,841 )
Net proceeds from issuance of shares and stock options
    19,464       1,439       40,505       4,967  
Net proceeds from issuance of bonds
                593,790        
Excess tax benefits from stock options
    6,226       (1,943 )     7,062       4,027  
Redemption and/or repayment of debt
    (1,530 )     (1,280 )     (1,875 )     (1,280 )
 
Net cash provided by (used in) financing activities
    24,160       (2,178 )     483,229       (187,730 )
 
                               
 
Net cash flows
    148,814       (49,596 )     794,477       41,707  
 
                               
Effect of changes in exchange rates on cash
    (2,846 )     1,691       (5,107 )     (350 )
 
Net increase (decrease) in cash & cash equivalents
    145,968       (47,905 )     789,370       41,357  

 


 

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations1,4
                                         
    Three months ended,  
(in millions EUR, except per share data)   Sep 30,
2007
    Dec 31,
2007
    Mar 30,
2008
    Jun 29,
2008
    Sep 28,
2008
 
 
 
                                       
Net system sales
    843.2       834.8       820.0       725.6       590.7  
Net service and field option sales
    91.2       120.1       99.2       118.6       105.8  
 
Total net sales
    934.4       954.9       919.2       844.2       696.5  
 
                                       
Cost of sales
    549.4       565.3       545.6       506.7       431.1  
 
Gross profit on sales
    385.0       389.6       373.6       337.5       265.4  
 
                                       
Research and development costs, net of credits
    120.1       129.3       128.3       130.2       130.2  
Selling, general and administrative costs
    56.0       56.9       57.3       56.4       51.9  
 
Income from operations
    208.9       203.4       188.0       150.9       83.3  
 
                                       
Interest income
    9.5       5.5       4.2       6.4       7.1  
 
Income from operations before income taxes
    218.4       208.9       192.2       157.3       90.4  
 
                                       
Benefit from (provision for) income taxes
    (52.1 )     (8.1 )     (47.1 )     34.7       (17.1 )
 
Net income
    166.3       200.8       145.1       192.0       73.3  
 
                                       
Basic net income per ordinary share
    0.35       0.46       0.34       0.45       0.17  
Diluted net income per ordinary share 2,3
    0.35       0.45       0.33       0.44       0.17  
 
                                       
Number of ordinary shares used in computing per share amounts (in thousands):
                             
Basic
    474,557       439,317       431,600       431,221       431,672  
Diluted 2,3
    481,724       444,569       434,959       434,585       434,491  
ASML — Quarterly Summary Ratios and other data 1,4
                                         
    Three months ended,  
    Sep 30,
2007
    Dec 31,
2007
    Mar 30,
2008
    Jun 29,
2008
    Sep 28,
2008
 
 
 
                                       
Gross profit as a % of net sales
    41.2       40.8       40.6       40.0       38.1  
Income from operations as a % of net sales
    22.4       21.3       20.5       17.9       12.0  
Net income as a % of net sales
    17.8       21.0       15.8       22.7       10.5  
Shareholders’ equity as a % of total assets
    35.7       46.5       44.5       49.7       50.3  
Income taxes as a % of income before income taxes
    23.9       3.9       24.5       (22.1 )     18.9  
Sales of systems total (in units)
    59       55       50       39       37  
ASP of system sales (EUR million)
    14.3       15.2       16.4       18.6       16.0  
Value of backlog systems total (EUR million)
    1,769       1,697       1,167       1,106       1,028  
Backlog systems total (in units)
    90       89       65       59       53  
ASP of backlog systems (EUR million)
    19.7       19.1       18.0       18.8       19.4  
Value of booking systems total (EUR million)
    857       803       312       632       498  
Net bookings total (in units)
    40       54       26       33       31  
ASP of bookings systems (EUR million)
    21.4       14.9       12.0       19.2       16.1  
Number of employees
    6,403       6,582       6,765       6,821       6,907  

 


 

ASML — Summary U.S. GAAP Consolidated Balance Sheets 1,4
                                         
(in millions EUR)   Sep 30,
2007
    Dec 31,
2007
    Mar 30,
2008
    Jun 29,
2008
    Sep 28,
2008
 
 
 
                                       
ASSETS
                                       
 
                                       
Cash and cash equivalents
    2,445.2       1,271.6       1,397.1       1,360.9       1,313.0  
Accounts receivable, net
    611.7       638.0       741.5       516.9       574.2  
Inventories, net
    1,021.2       1,102.2       1,152.0       1,130.2       1,134.0  
Deferred tax assets short-term
    131.3       73.0       71.1       69.8       82.8  
Other current assets
    214.2       234.6       267.6       262.2       261.4  
 
Total current assets
    4,423.6       3,319.4       3,629.3       3,340.0       3,365.4  
 
                                       
Deferred tax assets long-term
    143.5       141.0       135.8       157.7       139.4  
Other assets
    39.9       60.0       85.7       39.3       50.6  
Goodwill
    133.4       128.3       119.7       119.8       129.2  
Other intangible assets, net
    44.2       38.2       32.5       30.1       28.8  
Property, plant and equipment, net
    343.3       380.9       401.4       458.1       503.1  
 
Total assets
    5,127.9       4,067.8       4,404.4       4,145.0       4,216.5  
 
                                       
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                       
 
                                       
Current liabilities
    2,391.5       1,321.4       1,562.3       1,247.3       1,273.0  
Deferred tax and other liabilities
    248.3       245.4       261.5       227.0       215.2  
Other deferred liabilities
    8.2       8.0       7.1       18.5       8.8  
Convertible subordinated debt
    44.5                          
Other long-term debt
    604.0       602.0       615.3       591.6       596.7  
 
Total liabilities
    3,296.5       2,176.8       2,446.2       2,084.4       2,093.7  
 
                                       
Shareholders’ equity
    1,831.4       1,891.0       1,958.2       2,060.6       2,122.8  
 
Total liabilities and shareholders’ equity
    5,127.9       4,067.8       4,404.4       4,145.0       4,216.5  

 


 

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows 1,4
                                         
    Three months ended,  
    Sep 30,     Dec 31,     Mar 30,     Jun 29,     Sep 28,  
(in millions EUR)   2007     2007     2008     2008     2008  
 
 
                                       
CASH FLOWS FROM OPERATING ACTIVITIES
                                       
 
                                       
Net income
    166.3       200.8       145.1       192.0       73.3  
 
                                       
Depreciation and amortization
    28.0       29.8       30.6       26.5       29.2  
Disposals of property, plant and equipment
    1.7       1.6       1.1       1.3       1.4  
Share-based payments
    3.7       6.2       3.5       3.1       3.7  
Change in tax assets and liabilities
    (5.3 )     (0.6 )     21.8       (114.1 )     (6.0 )
Change in assets and liabilities
    (20.1 )     (157.9 )     65.2       21.2       (80.7 )
 
Net cash provided by operating activities
    174.3       79.9       267.3       130.0       20.9  
 
                                       
CASH FLOWS FROM INVESTING ACTIVITIES
                                       
 
                                       
Purchases of property, plant and equipment
    (49.7 )     (54.0 )     (55.0 )     (65.5 )     (68.3 )
Proceeds from sale of property, plant and equipment
          1.7                    
 
Net cash used in investing activities
    (49.7 )     (52.3 )     (55.0 )     (65.5 )     (68.3 )
 
                                       
CASH FLOWS FROM FINANCING ACTIVITIES
                                       
 
                                       
Capital repayment
          (1,011.9 )                  
Purchase of shares in conjunction with conversion rights of bond holders and stock options
          (203.6 )     (87.6 )            
Dividend paid
                      (107.4 )     (0.4 )
Net proceeds from issuance of shares and stock options
    19.5       22.8       3.0       0.5       1.4  
Excess tax benefits from stock options
    6.2       1.9             6.0       (1.9 )
Redemption and/or repayment of debt
    (1.5 )     (7.8 )                 (1.3 )
 
Net cash provided by (used in) financing activities
    24.2       (1,198.6 )     (84.6 )     (100.9 )     (2.2 )
 
                                       
 
Net cash flows
    148.8       (1,171.0 )     127.7       (36.4 )     (49.6 )
 
                                       
Effect of changes in exchange rates on cash
    (2.8 )     (2.6 )     (2.2 )     0.2       1.7  
 
Net increase (decrease) in cash & cash equivalents
    146.0       (1,173.6 )     125.5       (36.2 )     (47.9 )

 


 

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements
Basis of Presentation
ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).
Principles of consolidation
The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.
Use of estimates
The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.
Recognition of revenues
ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.
For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

 


 

ASML — Reconciliation U.S. GAAP — IFRS 1,4
Net income
                                 
    Three months ended,     Nine months ended,  
(in thousands EUR)   Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
Net income under U.S. GAAP
    166,279       73,294       478,460       410,394  
Share-based payments (see Note 1)
    280       (2,492 )     293       (3,009 )
Capitalization of development costs (see Note 2)
    9,594       14,867       29,575       55,197  
Convertible subordinated notes (see Note 3)
    (2,265 )           (6,661 )      
Income taxes (see Note 4)
          (3,119 )     (7,648 )     (3,081 )
 
Net income under IFRS
    173,888       82,550       494,019       459,501  
Shareholders’ equity
                                         
    Sep 30,     Dec 31,     Mar 30,     Jun 29,     Sep 28,  
(in thousands EUR)   2007     2007     2008     2008     2008  
 
Shareholders’ equity under U.S. GAAP
    1,831,438       1,890,948       1,958,159       2,060,575       2,122,848  
Share-based payments (see Note 1)
    7,126       787       (3,420 )     (3,266 )     (7,904 )
Capitalization of development costs (see Note 2)
    120,344       138,424       157,900       176,818       193,780  
Convertible subordinated notes (see Note 3)
    2,894                          
Income taxes (see Note 4)
          8,852       9,186       8,478       5,969  
 
Shareholders’ equity under IFRS
    1,961,802       2,039,011       2,121,825       2,242,605       2,314,693  
Notes to the reconciliation from U.S. GAAP to IFRS
Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.
Under U.S. GAAP, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.
Note 2 Capitalization of development costs
Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.
Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.
Note 3 Convertible Subordinated Notes
Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.
Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding. As of December 31, 2007 ASML has no Convertible Subordinated Notes outstanding.

 


 

Note 4 Income taxes
Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12, unrealized net income resulting from intercompany transactions that is eliminated from the carrying amount of assets on consolidation gives rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.
Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.
“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

 


 

 
1   All quarterly information in this press release is unaudited.
 
2   The calculation of diluted net income per ordinary share assumes conversion of our Subordinated Notes as such conversions would have a dilutive effect.
 
3   The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans as such exercises would have a dilutive effect.
 
4   As of January 1, 2008 ASML accounts for award credits offered to its customers as part of a volume purchase agreement using the deferred revenue model. Until December 31, 2007 the cost accrual method was used. This change in accounting policy was made because the deferred revenue model better reflects the business rationale. In addition the International Financial Reporting Interpretation Committee concludes in interpretation 13 (IFRIC 13 “Customer Loyalty Programmes”) that the deferred revenue model is the appropriate accounting treatment. Comparative figures for 2007 were adjusted to reflect this change in accounting policy. The impact of this change on equity as per January 1, 2007 amounted to EUR 8.1 million (decrease) and on net income for the year 2007 and the first quarter of 2008 amounted to EUR 8.6 million (decrease) and EUR 0.1 million (increase) respectively.

 

EX-99.3 4 u56735exv99w3.htm EXHIBIT 99.3 exv99w3
Exhibit 99.3
ASML — Summary IFRS Consolidated Income Statements 1,2
                                 
    Three months ended,     Nine months ended,  
(in thousands EUR)   Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
 
                               
Net system sales
    843,232       590,723       2,516,425       2,136,296  
Net service and field option sales
    91,142       105,770       296,842       323,562  
 
Total net sales
    934,374       696,493       2,813,267       2,459,858  
 
                               
Cost of sales
    581,839       452,713       1,735,058       1,539,628  
 
Gross profit on sales
    352,535       243,780       1,078,209       920,230  
 
                               
Research and development costs, net of credits
    76,886       88,571       268,236       258,360  
Selling, general and administrative costs
    55,977       52,245       168,449       165,272  
 
Operating income
    219,672       102,964       641,524       496,598  
 
                               
Interest income
    9,089       6,599       21,571       15,147  
 
Income before income taxes
    228,761       109,563       663,095       511,745  
 
                               
Provision for income taxes
    (54,873 )     (27,013 )     (169,076 )     (52,244 )
 
Net income
    173,888       82,550       494,019       459,501  

 


 

ASML — Summary IFRS Consolidated Balance Sheets 1,2
                 
(in thousands EUR)   Dec 31, 2007     Sep 28, 2008  
 
 
               
ASSETS
               
 
               
Property, plant and equipment
    380,894       503,057  
Goodwill
    136,246       137,273  
Other intangible assets
    216,908       281,323  
Deferred tax assets
    220,863       228,605  
Derivative financial instruments
    20,930       12,297  
Other non-current assets
    32,828       32,607  
 
Total non-current assets
    1,008,669       1,195,162  
 
               
Inventories
    1,102,210       1,134,039  
Derivative financial instruments
    12,319       20,953  
Accounts receivable, net
    637,975       574,230  
Other current assets
    193,415       210,579  
Cash and cash equivalents
    1,271,636       1,312,993  
 
Total current assets
    3,217,555       3,252,794  
 
               
Total assets
    4,226,224       4,447,956  
 
               
EQUITY AND LIABILITIES
               
 
               
Equity
    2,039,011       2,314,693  
 
               
Other long-term debt
    595,783       590,971  
Derivative financial instruments
          891  
Deferred tax and other liabilities
    257,325       256,866  
Other deferred liabilities
    7,935       7,859  
 
Total non-current liabilities
    861,043       856,587  
 
               
Accounts payable
    282,953       270,932  
Accrued liabilities and other
    927,841       948,139  
Current tax liabilities
    104,095       42,395  
Derivative financial instruments
    11,281       15,210  
 
Total current liabilities
    1,326,170       1,276,676  
 
               
Total equity and liabilities
    4,226,224       4,447,956  

 


 

ASML — Summary IFRS Consolidated Statements of Cash Flows 1,2
                                 
    Three months ended,     Nine months ended,  
(in thousands EUR)   Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
 
                               
CASH FLOWS FROM OPERATING ACTIVITIES
                               
 
                               
Net income
    173,888       82,550       494,019       459,501  
 
                               
Depreciation and amortization
    58,330       50,662       161,211       142,247  
Disposals of property, plant and equipment
    1,698       1,413       12,572       3,827  
Share-based payments
    3,675       3,581       10,342       9,858  
Change in tax assets and liabilities
    3,928       2,242       28,486       (70,426 )
Change in assets and liabilities
    (6,268 )     (80,071 )     6,342       7,279  
 
Net cash provided by operating activities
    235,251       60,377       712,972       552,286  
 
                               
CASH FLOWS FROM INVESTING ACTIVITIES
                               
 
                               
Purchases of property, plant and equipment
    (49,676 )     (68,237 )     (125,188 )     (188,711 )
Proceeds from sale of property, plant and equipment
                3,355        
Purchases of intangible assets
    (60,659 )     (41,502 )     (96,138 )     (130,111 )
Acquisition of subsidiary (net of cash acquired)
                (188,011 )      
 
Net cash used in investing activities
    (110,335 )     (109,739 )     (405,982 )     (318,822 )
 
                               
CASH FLOWS FROM FINANCING ACTIVITIES
                               
 
                               
Purchase of shares in conjunction with conversion rights of bond holders and stock options
                (156,253 )     (87,603 )
Dividend paid
          (394 )           (107,841 )
Net proceeds from issuance of shares and stock options
    25,428       1,439       51,825       4,967  
Net proceeds from issuance of bonds
                593,790        
Redemption and/or repayment of debt
    (1,530 )     (1,280 )     (1,875 )     (1,280 )
 
Net cash provided by (used in) financing activities
    23,898       (235 )     487,487       (191,757 )
 
                               
 
Net cash flows
    148,814       (49,597 )     794,477       41,707  
Effect of changes in exchange rates on cash
    (2,846 )     1,692       (5,107 )     (350 )
 
Net increase (decrease) in cash & cash equivalents
    145,968       (47,905 )     789,370       41,357  

 


 

ASML — Quarterly Summary IFRS Consolidated Income Statements 1,2
                                         
    Three months ended,  
    Sep 30,     Dec 31,     Mar 30,     Jun 29,     Sep 28,  
(in millions EUR)   2007     2007     2008     2008     2008  
 
 
                                       
Net system sales
    843.2       834.9       820.0       725.6       590.7  
Net service and field option sales
    91.2       120.0       99.2       118.6       105.8  
 
Total net sales
    934.4       954.9       919.2       844.2       696.5  
 
                                       
Cost of sales
    581.9       583.7       561.7       525.3       452.7  
 
Gross profit on sales
    352.5       371.2       357.5       318.9       243.8  
 
                                       
Research and development costs, net of credits
    76.8       84.7       82.7       87.1       88.6  
Selling, general and administrative costs
    56.0       73.5       57.7       55.3       52.2  
 
Operating income
    219.7       213.0       217.1       176.5       103.0  
 
                                       
Interest income (charges)
    9.1       (2.2 )     3.6       5.0       6.6  
 
Income before income taxes
    228.8       210.8       220.7       181.5       109.6  
 
                                       
Benefit from (provision for) income taxes
    (54.9 )     18.5       (54.2 )     29.0       (27.0 )
 
Net income
    173.9       229.3       166.5       210.5       82.6  

 


 

ASML — Summary IFRS Consolidated Balance Sheets 1,2
                                         
    Sep 30,     Dec 31,     Mar 30,     Jun 29,     Sep 28,  
(in millions EUR)   2007     2007     2008     2008     2008  
 
 
                                       
ASSETS
                                       
 
                                       
Property, plant and equipment
    343.3       380.9       401.4       458.1       503.1  
Goodwill
    141.7       136.3       127.2       127.3       137.3  
Other intangible assets
    198.4       216.9       238.0       260.5       281.3  
Deferred tax assets
    252.3       220.9       213.3       238.4       228.6  
Derivative financial instruments
    9.9       20.9       47.7       1.4       12.3  
Other non-current assets
    33.3       32.8       31.8       32.0       32.6  
 
Total non-current assets
    978.9       1,008.7       1,059.4       1,117.7       1,195.2  
 
                                       
Inventories
    1,021.2       1,102.2       1,152.0       1,130.2       1,134.0  
Derivative financial instruments
    23.5       12.3       36.5       46.6       21.0  
Accounts receivable, net
    611.7       638.0       741.5       516.9       574.2  
Other current assets
    211.8       193.4       202.4       185.9       210.6  
Cash and cash equivalents
    2,445.2       1,271.6       1,397.1       1,360.9       1,313.0  
 
Total current assets
    4,313.4       3,217.5       3,529.5       3,240.5       3,252.8  
 
                                       
Total assets
    5,292.3       4,226.2       4,588.9       4,358.2       4,448.0  
 
                                       
EQUITY AND LIABILITIES
                                       
 
                                       
Equity
    1,961.8       2,039.0       2,121.8       2,242.6       2,314.7  
 
                                       
Convertible subordinated debt
    40.1                          
Other long-term debt
    597.8       595.8       609.1       585.6       591.0  
Derivative financial instruments
    0.7                   11.2       0.9  
Deferred tax and other liabilities
    259.3       257.3       282.9       260.2       256.9  
Other deferred liabilities
    8.2       7.9       7.2       7.4       7.8  
 
Total non-current liabilities
    906.1       861.0       899.2       864.4       856.6  
 
                                       
Accounts payable
    320.9       283.0       479.6       267.2       271.0  
Accrued liabilities and other
    1,933.0       927.8       957.7       910.8       948.1  
Current tax liabilities
    151.9       104.1       111.5       50.8       42.4  
Derivative financial instruments
    18.6       11.3       19.1       22.4       15.2  
 
Total current liabilities
    2,424.4       1,326.2       1,567.9       1,251.2       1,276.7  
 
                                       
Total equity and liabilities
    5,292.3       4,226.2       4,588.9       4,358.2       4,448.0  

 


 

ASML — Summary IFRS Consolidated Statements of Cash Flows 1,2
                                         
    Three months ended,  
    Sep 30,     Dec 31,     Mar 30,     Jun 29,     Sep 28,  
(in millions EUR)   2007     2007     2008     2008     2008  
 
 
                                       
CASH FLOWS FROM OPERATING ACTIVITIES
                                       
 
                                       
Net income
    173.9       229.3       166.5       210.5       82.6  
 
                                       
Depreciation and amortization
    58.3       49.2       46.8       44.8       50.7  
Disposals of property, plant and equipment
    1.7       1.6       1.1       1.3       1.4  
Share-based payments
    3.7       6.8       3.4       2.9       3.6  
Change in tax assets and liabilities
    4.0       (26.7 )     29.7       (102.4 )     2.2  
Change in assets and liabilities
    (6.3 )     (126.6 )     65.4       21.9       (80.1 )
 
Net cash provided by operating activities
    235.3       133.6       312.9       179.0       60.4  
 
                                       
CASH FLOWS FROM INVESTING ACTIVITIES
                                       
 
                                       
Purchases of property, plant and equipment
    (49.7 )     (54.0 )     (55.1 )     (65.4 )     (68.2 )
Proceeds from sale of property, plant and equipment
          1.7                    
Purchases of intangible assets
    (60.7 )     (40.4 )     (45.5 )     (43.1 )     (41.5 )
 
Net cash used in investing activities
    (110.4 )     (92.7 )     (100.6 )     (108.5 )     (109.7 )
 
                                       
CASH FLOWS FROM FINANCING ACTIVITIES
                                       
 
                                       
Capital repayment
          (1,011.9 )                  
Purchase of shares in conjunction with conversion rights of bond holders and stock options
          (203.6 )     (87.6 )            
Dividend paid
                      (107.5 )     (0.4 )
Net proceeds from issuance of shares and stock options
    25.4       11.5       3.0       0.6       1.4  
Redemption and/or repayment of debt
    (1.5 )     (7.9 )                 (1.3 )
 
Net cash provided by (used in) financing activities
    23.9       (1,211.9 )     (84.6 )     (106.9 )     (0.3 )
 
                                       
 
Net cash flows
    148.8       (1,171.0 )     127.7       (36.4 )     (49.6 )
 
                                       
Effect of changes in exchange rates on cash
    (2.8 )     (2.6 )     (2.2 )     0.2       1.7  
 
Net increase (decrease) in cash & cash equivalents
    146.0       (1,173.6 )     125.5       (36.2 )     (47.9 )

 


 

ASML — Notes to the Summary IFRS Consolidated Financial Statements
Basis of Presentation
ASML has prepared the accompanying summary consolidated financial statements in accordance with International Financial Reporting Standards (“IFRS”) as adopted by the EU — accounting principles generally accepted in the Netherlands for companies quoted on Euronext Amsterdam. Further disclosures, as required under IFRS in annual reports and interim reporting (IAS 34), are not included. The accompanying consolidated financial statements are stated in thousands of euros (‘EUR’), except otherwise indicated.
For internal and external reporting purposes, ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP is ASML’s primary accounting standard for the Company’s setting of financial and operational performance targets.
Principles of consolidation
The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.
Use of estimates
The preparation of ASML’s consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.
Recognition of revenues
ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.
For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

 


 

ASML — Reconciliation U.S. GAAP — IFRS 1,2
Net income
                                 
    Three months ended,     Nine months ended,  
(in thousands EUR)   Sep 30, 2007     Sep 28, 2008     Sep 30, 2007     Sep 28, 2008  
 
Net income under U.S. GAAP
    166,279       73,294       478,460       410,394  
Share-based payments (see Note 1)
    280       (2,492 )     293       (3,009 )
Capitalization of development costs (see Note 2)
    9,594       14,867       29,575       55,197  
Convertible subordinated notes (see Note 3)
    (2,265 )           (6,661 )      
Income taxes (see Note 4)
          (3,119 )     (7,648 )     (3,081 )
 
Net income under IFRS
    173,888       82,550       494,019       459,501  
Shareholders’ equity
                                         
    Sep 30,     Dec 31,     Mar 30,     Jun 29,     Sep 28,  
(in thousands EUR)   2007     2007     2008     2008     2008  
 
Shareholders’ equity under U.S. GAAP
    1,831,438       1,890,948       1,958,159       2,060,575       2,122,848  
Share-based payments (see Note 1)
    7,126       787       (3,420 )     (3,266 )     (7,904 )
Capitalization of development costs (see Note 2)
    120,344       138,424       157,900       176,818       193,780  
Convertible subordinated notes (see Note 3)
    2,894                          
Income taxes (see Note 4)
          8,852       9,186       8,478       5,969  
 
Shareholders’ equity under IFRS
    1,961,802       2,039,011       2,121,825       2,242,605       2,314,693  
Notes to the reconciliation from U.S. GAAP to IFRS
Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.
Under U.S. GAAP, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.
Note 2 Capitalization of development costs
Under IFRS, ASML applies IAS 38, “Intangible Assets”. In accordance with IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.
Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.
Note 3 Convertible Subordinated Notes
Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.
Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding. As of December 31, 2007 ASML has no Convertible Subordinated Notes outstanding.

 


 

Note 4 Income taxes
Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12, unrealized net income resulting from intercompany transactions that is eliminated from the carrying amount of assets on consolidation gives rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.
Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.
“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, credit market deterioration on consumer confidence which could affect our customers, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

 


 

 
1   All quarterly information in this press release is unaudited.
 
2   In anticipation of endorsement by the European Union in Q4 2008, ASML has early adopted IFRIC 13 “Customer Loyalty Programmes” as of January 1, 2008. IFRIC 13 requires award credits offered to its customers as part of a volume purchase agreement to be accounted for using the deferred revenue model. Until December 31, 2007 cost accrual method was used. ASML early adopted this interpretation because the deferred revenue model better reflects the business rationale for offering award credits. Comparative figures for 2007 were adjusted to reflect this change in accounting policy. The impact of this change on equity as per January 1, 2007 amounted to EUR 8.1 million (decrease) and on net income for the year 2007 and the first quarter of 2008 amounted to EUR 8.6 million (decrease) and EUR 0.1 million (increase) respectively.

 

GRAPHIC 5 u56735u5673501.gif GRAPHIC begin 644 u56735u5673501.gif M1TE&.#EACP`I`/?Z``$!`0("`OW]_?S\_.OKZY.3DR0D))65E?KZ^DI*2NSL M[/?W]P,#`^3DY.CHZ.7EY?CX^._O[_;V]A45%0@("!<7%P0$!/O[^P4%!08& M!O/S\_GY^3,S,SP\//3T].[N[D-#0^KJZHZ.CAD9&?'Q\=?7UQT='924E/+R M\E=75\K*RM+2T@D)";.SLQX>'O7U]WM[9:6EK&QL8J*BN+BXAL;&QH: M&@<'!Y*2DBDI*?#P\*NKJS8V-GU]?41$1,?'QR(B(L[.SH"`@,W-S:^OKX&! M@;6UM4]/3WM[>ZVMK4!`0#4U-2@H*.?GYRWK2T MM"4E):.CH]W=W>#@X*FIJ=C8V-#0T']_?Y"0D(^/CR$A(<+"PD5%15U=7=_? MWS7@T-#;V]O1$1$4Y.3NGIZ:"@ MH+N[NPL+"VAH:'1T=')R=75U:RLK**BHMK:VDE)23\_ M/VEI:79V=KZ^OD%!02,C(VMK:Y>7EWIZ>J6EI6%A88B(B&QL;%%147-SGI]O;VZ&AH6UM;7!P<(V-C5E9649&1K^_OQ(2$E]? M7VYN;LS,S&1D9.'AX;BXN#DY.28F)DQ,3%965K:VMF9F9EI:6CT]/<_/SXR, MC+>WMV5E9;R\O(:&AG%Q<:2DI#HZ.L7%Q;*RLL3$Q&IJ:M'1T=G9V::FIGQ\ M?`X.#C(R,GY^?D='1\#`P'AX>%Q<7&)B8L/#PS`P,`\/#RPL+(>'AV-C8TA( M2"TM+9J:FI^?GXF)B9N;FYZ>GB`@((.#@YRD!SJ]NW$;L:3`A,TC(-9$.=Q2="PH\$ M*^$*'IQ/+D&$="2YT=`"@UYI^'(M2,"`QQ0RA+T&SK-(6:B+Y\:&$ MN;4U4`X8)&@B``$$@&22^(`2TD!:@(B/)@5IT`:(3$A`$`%!1/A)BO&-=@\0 M*@PT@"(*X)(6!$@`8$T>05A1PD'W0#!#0S;18**&K`B93Q$X2*F@B5\4=(J& M`>"3`'P";3&!A":J40--"E@180)@&J3:.'&4.1`<$YBQ`1+XU/&`%09L06<^ M$1C008,\5O\D`1J#1KC&3`1I4`8^>R9H@AC'3+)&!OA(041;A4":*!@1$)1( MKT8"D,$H-!%@P*69%J033V$HT0`'D@@QD``EY&$,`)PT8$`0=^0CP#T#;%/+ M)7^08E2L$ZG0AX),1*$@!M02%,:/">+@`WCYH#!(!VR\0!`"'2@HAQQ[&DN0 M#[SB0\$?2B9X0K77*HBIB@+!APH^5\1PQ@CB#D2'"WLX8$4IJA:(1BD/J/`' M&@V69$3&M9$2X1`%11FA&`_5\#%!7_\P*$)K*P MR1L1+B.:0UITG"`(Z!5(4T*S$)NH&,DJ*,I`#9B`)#YEB`(T"!=T'7*"(R_% MJ"Q3(E!V)Q]@8@RC@^B99A#53-B[1`"5$0`+<5"$$.FB"`V#0C8^(A#9, M2D,^&H"(!"7J':>9H`N`EB`[C*,><(B(*GAEHEQ<@U@):H,#!#(/$N*C"\!@ M@<3:)1"OB2Q;!$G)-2APC'S\+`D(T`4^_Z9!@$S80!LKJ,`/CC`"-+2/<'T! M1P".$(@FZ"`$,.C#.IJ%KX'L@`U&LL`,\G$!0&3-1"`8WT"&(*A>`$()OB'( M`LZ@(`:T0!@54-`Y8'`01@PJ%2$`@X("H`7WW1`E2?C"',)`@13X$!]`?`0^ M>$``-MA@"B4P`3X6H0%.8.,%:.G++BQ@"0<\00<*H`,A0-`SB@S">PEJ0OOR MD8LSXJ,74Z`)"5(@J`0A(7L.\40<%*2&34"``X,2!*O6H*`^$`$!$%)0-`Q) M.AP.1!^>R\0'PL`"70B`C9'$7Q8848(2;'`1Z@&`*B[P"WQ\80%B8(`S3*D# M`HQ"&4:I""LBY/^+`2#@`D`@!-`HT18))$&3$:K>GKSA!(<4P7E-:!8?C(0/ M"<)`H`D*@D0CI`=J*LJ:J%P-JPFR9AA`DQ$P`]2&,,],/:-'>"B M&K5`!#%VD`\5J.$'%TA%`,AQ`5/@HP`O^$$&+%&+9S3D713A0?4H:B0AR$A! M(T"801[`@T?(D%>)"L(*[R%)!<%"(#-(E(ETX(%;1,@(`ME#A.(`S+3_?I1D M^5B!"3CP`;B.(1\8\X)`J""*&"###0I0@1&T=`4&!(.=^#B!!T`0@)8-52#W M@Q0^W)`/9,`R0;2@2!WRJ"`IA"$?)$!',@7B"35D;`**^,$@$R$0($A!08NM MX>AN&R:!K,`&O!T$!?C@`1I`@R9'P$$K(D`"@G0B`,&X1RCP<0`GH`(+&'G` M"*1$-"?LMQ`5:030:@13?R5(#D`0B`>@D+4`X.``3U#0'W24CP<(,F.GT._[ M-(6>?'#A!DS80>3$43*!%*&1"#`$%-JWDBO@HQ`7$'$11F*+"&6@!QUPPQ*. M)0!E1.@)&N`;02:Z)P8<(1^"55`;YC`0(3(@_TF.Z(6".'`X".PJ8[C0L8(` M$1>#",$&90B$)7A!DQE0X!4(X`8D'8"%`@D"'Z900`Y"N!%>*N@'+QC``+"3 MD`-$R`('OD<-#F&++5A((#&(AXD3%`=5:>)S<P3&":FCG270/#`@E8L0-&B&"'$"+#T,L.T$3T($QC@$.2TDHC0,PXYYN01!K%&F0>Q(N3^KWHS88 M):W.TU`95,,%>UPG(56@0"P6@+$N;"`6`-!"`^!0(&343-L"H42$_K""AT@@ M8DS*!%8.(:@DF0@'P__(1PB*`309$`0+[HV6B2Q`:)YPP@(_(D2*TSI9$(E` M-:=)R!%8``@(L+$+"&@%/JKP`2@X8D48$<`DCA:ZA]1/03B`@0;`*"6M4<#E M/<$H/BPP"()(P!P@&@&N!"*$5>-C&RWJ4B_QP0`5J.8>[Q(`#RB`!`FL]!L7 M>`4#BA`!#LBC!%P@T$$@BQ$N?#9!-(@(+R0TA!K$N)=,F,5`X!&A/F2A():6 M$"BR%0BJ*N@-*K?#W/%A@`4`72`[.,,D%O`S'VR`$1C@`0IZ8((LW&$"P1B` MXRR"D!)X(0<%R,$)A#'\@:#`'9`H0`%$4(5[.*`%XHA$#UQP`QNTH0.FX$3_ MF!U"!Q%(/P>"B'5]O2#]]HL@Y0^[0O0+\(6R+Z`3\V^__NE_G-?C?05.0#@^ M@``I``")@`),X`)4L`(3<`:YA'&-\Q",1Q&;`0$Q,`<-$`,XA'<[$1%=!(&O MYQ`V]@8;<#]XL'LF0`:@T@-L`8$]IADPV#C--QI!UX%S,8.!@1!#M1(A.!!9 MX`2\LP!$]J&PK``57L`-$B`6;4`$<\%A+V(1< M*!%/N!(H\`!,<`-3,`58B"=;V(5JR&,8<0FDL`+:8`-0,"DSN(9VB!%/V&,# MD`T5D`EYX"YI>(=WF(<%$0:,\(>!*(B#J`^,V(B.%OB(D!B)DCB)E%B)EGB) *F)B)FAB)`0$`.S\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----